Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer.
暂无分享,去创建一个
[1] Clare Allen,et al. 855 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) HEMIABLATION TRIAL IN LOCALISED UNILATERAL PROSTATE CANCER: INTERIM RESULTS , 2009 .
[2] M. Schostak,et al. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. , 2008, Urology.
[3] A. Evans,et al. Vascular‐targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses , 2008, BJU international.
[4] H. Ahmed,et al. Re: Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2008, The Journal of urology.
[5] Keith A. Cengel,et al. Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen , 2008, Clinical Cancer Research.
[6] M. Rouprêt,et al. Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer , 2008, World Journal of Urology.
[7] Bernhard Walter,et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. , 2008, European urology.
[8] H. Ahmed,et al. Transrectal high intensity focused ultrasound in the treatment of localised prostate cancer-the first UK series , 2008 .
[9] M. Schostak,et al. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. , 2008, European urology.
[10] Jeffrey K. Cohen,et al. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. , 2008, Urology.
[11] S. Horie,et al. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. , 2008, Japanese journal of clinical oncology.
[12] Clare Allen,et al. MR imaging of prostate after treatment with high-intensity focused ultrasound. , 2008, Radiology.
[13] J. Rewcastle,et al. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. , 2007, Urology.
[14] Oliver Sartor,et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.
[15] G. Onik,et al. "Male lumpectomy": focal therapy for prostate cancer using cryoablation. , 2007, Urology.
[16] A. Evans,et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. , 2007, The Journal of urology.
[17] Hashim Uddin Ahmed,et al. Will focal therapy become a standard of care for men with localized prostate cancer? , 2007, Nature Clinical Practice Oncology.
[18] V. Mouraviev,et al. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. , 2007, Urology.
[19] Robert A Weersink,et al. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. , 2007, Radiology.
[20] E. Crawford,et al. Target focal therapy in early prostate cancer: Initial single institution results , 2007 .
[21] J. Rewcastle,et al. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. , 2007, Urology.
[22] Laura Curiel,et al. Control of prostate cancer by transrectal HIFU in 227 patients. , 2007, European urology.
[23] Constantin Coussios,et al. High intensity focused ultrasound: Physical principles and devices , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[24] G. Martignoni,et al. Short‐term outcome after high‐intensity focused ultrasound in the treatment of patients with high‐risk prostate cancer , 2006, BJU international.
[25] J. Rewcastle,et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. , 2006, Journal of endourology.
[26] Paul Schellhammer,et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.
[27] M Emberton,et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer , 2006, Lasers in surgery and medicine.
[28] N. Sheikh,et al. Third‐generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease , 2006, BJU international.
[29] C. Mosse,et al. VASCULAR-TARGETED PHOTODYNAMIC THERAPY IN ORGAN CONFINED PROSTATE CANCER -REPORT OF A NOVEL PHOTOSENSITISER , 2006 .
[30] R. Weersink,et al. Photodynamic therapy for urological malignancies: past to current approaches. , 2006, The Journal of urology.
[31] Toyoaki Uchida,et al. Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer , 2006, International journal of urology : official journal of the Japanese Urological Association.
[32] Toyoaki Uchida,et al. Treatment of localized prostate cancer using high‐intensity focused ultrasound , 2006, BJU international.
[33] K. Wallner,et al. Prostate cryotherapy: more questions than answers. , 2005, Urology.
[34] A. Katz,et al. Cryosurgical ablation of the prostate , 2005, Cancer.
[35] E. H. Lambert,et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. , 2005, Urology.
[36] A. Haese*,et al. Surgical management of prostate cancer: advances based on a rational approach to the data. , 2005, European journal of cancer.
[37] J. Kennedy. High-intensity focused ultrasound in the treatment of solid tumours , 2005, Nature Reviews Cancer.
[38] Guy Vallancien,et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. , 2004, The Journal of urology.
[39] B. Norlén,et al. A systematic overview of radiation therapy effects in prostate cancer , 2004, Acta oncologica.
[40] Bernhard Walter,et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. , 2004, Urology.
[41] Amnon Zisman,et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. , 2003, The Journal of urology.
[42] Guy Vallancien,et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.
[43] S. Cytron,et al. Active rectal wall protection using direct transperineal cryo-needles for histologically proven prostate adenocarcinomas. , 2003, European urology.
[44] C. Chaussy,et al. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection , 2003, Current urology reports.
[45] B. Donnelly,et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. , 2002, Urology.
[46] Stephen G Bown,et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. , 2002, The Journal of urology.
[47] Anil Kumar,et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. , 2002, Urology.
[48] John C Bischof,et al. The cryobiology of cryosurgical injury. , 2002, Urology.
[49] J. Hugosson,et al. Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study. , 2002, European urology.
[50] G. Onik,et al. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. , 2002, Urology.
[51] Olivier Rouvière,et al. MRI Appearance of Prostate following Transrectal HIFU Ablation of Localized Cancer , 2001, European Urology.
[52] J. Chapelon,et al. Transrectal High Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Factors Influencing the Outcome , 2001, European Urology.
[53] K. Shinohara,et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. , 2001, Urology.
[54] P. Carroll,et al. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. , 1999, The Journal of urology.
[55] James D. Cox,et al. Consensus statement: Guidelines for PSA following radiation therapy , 1997 .
[56] J. Cohen,et al. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. , 1996, Urology.
[57] C R Hill,et al. Review article: high intensity focused ultrasound--potential for cancer treatment. , 1995, The British journal of radiology.
[58] S. Andersson,et al. Photodynamic therapy of localised prostatic cancer , 1990, The Lancet.
[59] G. Muto,et al. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience. , 2009, The Journal of urology.
[60] Timothy C Zhu,et al. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[61] Robert A Weersink,et al. Assessment of Cutaneous Photosensitivity of TOOKAD (WST09) in Preclinical Animal Models and in Patients¶ , 2005, Photochemistry and photobiology.
[62] Ronald Sroka,et al. Photodynamic Therapy by Means of 5-ALA Induced PPIX in Human Prostate Cancer – Preliminary Results , 2003 .